Results 81 to 90 of about 7,444 (141)

Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 6710. [PDF]

Int J Mol Sci
Nishimura N, Kaji K, Nishimura N, Hanatani J, Nakatani T, Oyama M, Shibamoto A, Tsuji Y, Kitagawa K, Sato S, Namisaki T, Tamaoki S, Yoshiji H.   +12 more
europepmc   +1 more source

Editorial: Rifaximin and the Gut-Liver-Brain Axis-Progress and Prudence. [PDF]

Aliment Pharmacol Ther
Houston KV, Bajaj JS.
europepmc   +1 more source

[Rifaximin].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2004
M, Gobernado, J, Ponce
openaire   +1 more source

Treatment of Small Intestinal Bacterial Overgrowth (SIBO) in Gastrointestinal, Hepatic, Endocrine, Neurological, and Postoperative Diseases: A Comprehensive Narrative Review. [PDF]

Med Sci (Basel)
Maslennikov R, Agarkova V, Poluektova E, Ulyanin A, Zolnikova O, Kurbatova A, Kozlov E, Demina T, Zharikov Y, Sigidaev A, Ivashkin V.   +10 more
europepmc   +1 more source

Minimal Hepatic Encephalopathy: A Narrative Review. [PDF]

Cureus
Pitton Rissardo J, Rashidi F, Moharam H, Khalil I, Bahar M, Rashidi M, Ahmed B, Salem S, Fornari Caprara AL, Chouthai AA, Kedwany AM, Sayed HH, Prathiraja O, Jayasinghe M.   +13 more
europepmc   +1 more source

Letter: Interpretation of Cognitive and Clinical Outcomes in the Randomized Trial of Rifaximin for Covert Hepatic Encephalopathy. Authors' Reply. [PDF]

Aliment Pharmacol Ther
Inada H, Tanaka Y.
europepmc   +1 more source

Clinical guideline: ACG clinical guideline on hepatic encephalopathy. [PDF]

J Hosp Med
Patel N.
europepmc   +1 more source

Extracellular vesicles from plasma of patients with minimal hepatic encephalopathy induce neuroinflammation and cognitive impairment in rats, which are prevented by treating the patients with rifaximin. [PDF]

J Neuroinflammation
Lopez-Gramaje A, Arenas YM, Gallego JJ, Izquierdo-Altarejos P, Urios A, Escudero-García D, Benlloch S, Kosenko E, Felipo V, Montoliu C.   +9 more
europepmc   +1 more source

Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report. [PDF]

Am J Case Rep
Dey R, Popuri H, Gulla V, Chirrareddy Y, Paritala S, Bustamante D, Corral J.   +6 more
europepmc   +1 more source

Platelet activation and short-term rifaximin therapy in decompensated cirrhosis: a pilot randomized controlled study. [PDF]

Intern Emerg Med
Di Cola S, Maiorca F, Stefanini L, Sabetta A, Lombardi L, D'Amico T, Lapenna L, Castellani V, Romiti GF, Cangemi R, Riggio O, Raparelli V, Merli M, Basili S.   +13 more
europepmc   +1 more source